IMP-13-producing Pseudomonas monteilii recovered in a hospital environment

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 10, 2011, Pages 2434-2435

  Bogaerts, Pierre ^a   Bouchahrouf, Warda ^a   Lissoir, Benedicte ^b   Denis, Olivier ^c   Glupczynski, Youri ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b Grand Hopital de Charleroi   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Carbapenem resistance; Metallo lactamases; Pseudomonas putida; Resistance gene reservoirs

Indexed keywords

AZTREONAM; CARBAPENEM; CEFTAZIDIME; COLISTIN; IMIPENEM; IMP 13; MEROPENEM; METALLO BETA LACTAMASE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM EXAMINATION; DISEASE ASSOCIATION; EMERGENCY CARE; GENE SEQUENCE; HAND WASHING; HEALTH CARE FACILITY; HEALTH CARE ORGANIZATION; HEALTH EDUCATION; HOSPITAL; HOSPITAL HYGIENE; HOSPITAL INFECTION; INFECTION CONTROL; INTEGRON; LETTER; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPERATING ROOM; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS MONTEILII; PSEUDOMONAS PUTIDA;

ANTI-BACTERIAL AGENTS; BELGIUM; BETA-LACTAMASES; BURN UNITS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EQUIPMENT CONTAMINATION; FOMITES; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS;

EID: 80052886009     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr294     Document Type: Letter

References (7)

1. IMP-13, harboured by a novel Tn5051-type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme. J Antimicrob Chemother 2003; 52: 583-90.
2. Pagani L, Colinon C, Migliavacca R et al. Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-b-lactamase. J Clin Microbiol 2005; 43: 3824-8.
3. Santella G, Pollini S, Docquier JD et al. Intercontinental dissemination of IMP-13-producing Pseudomonas aeruginosa belonging in sequence type 621. J Clin Microbiol 2010; 48: 4342-3.
4. Juan C, Zamorano L, Mena A et al. Metallo-β-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones. J Antimicrob Chemother 2010; 65: 474-8.
5. Elomari M, Coroler L, Verhille S et al. Pseudomonas monteilii sp. nov., isolated from clinical specimens. Int J Syst Bacteriol 1997; 47: 846-52.
6. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twentieth Informational Supplement M100-S20. CLSI, Wayne, PA, USA, 2010.
7. Docquier JD, Riccio ML, Mugnaioli C et al. IMP-12, a new plasmid-encoded metallo-β-lactamase from a Pseudomonas putida clinical isolate. Antimicrob Agents Chemother 2003; 47: 1522-8.